Stocktoria
Haleon plc HLN.L
GB · London Stock Exchange · XLON · stock · Healthcare · website
Haleon plc financials (annual)
Bars are annual figures from 2022 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | £11.0B | £11.2B | £11.3B | £10.9B |
| Gross profit | £7.1B | £6.8B | £6.7B | £6.6B |
| R&D expense | £316.0M | £298.0M | £311.0M | £300.0M |
| SG&A expense | £4.4B | £4.5B | £4.4B | £4.5B |
| Operating income | £2.4B | £2.2B | £2.0B | £1.8B |
| Interest expense | £347.0M | £394.0M | £414.0M | £278.0M |
| Income tax | £472.0M | £435.0M | £517.0M | £499.0M |
| Net income | £1.7B | £1.4B | £1.0B | £1.1B |
| EPS (diluted) | — | £0.16 | £0.11 | £0.12 |
| Operating cash flow | £2.6B | £2.3B | £2.1B | £2.1B |
| Free cash flow | £2.2B | £2.0B | £1.8B | £1.7B |
| Cash & equivalents | £1.3B | £2.2B | £994.0M | £606.0M |
| Inventory | £1.0B | £1.2B | £1.4B | £1.3B |
| Goodwill | £8.1B | £8.2B | £8.3B | £8.4B |
| Total assets | £32.6B | £34.3B | £34.1B | £34.8B |
| Total debt | £8.6B | £10.1B | £9.4B | £10.4B |
| Total liabilities | £16.1B | £18.1B | £17.3B | £18.4B |
| Shareholders' equity | £16.4B | £16.2B | £16.6B | £16.3B |
| Share buybacks | £654.0M | £619.0M | £0 | £0 |
Growth · year-over-year · Revenue CAGR 0.5%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue growth | -1.8% | -0.6% | +4.1% | — |
| Net income growth | +15.6% | +37.5% | -1.0% | — |
| EPS growth | — | +38.9% | -1.7% | — |
| Free cash flow growth | +12.0% | +12.4% | +1.7% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · GB · as of 2025-12-31. Figures in GBP. Facts plus Stocktoria's own computed scores — not investment advice.